Sniffing away eye damage: new nasal spray trial offers hope for diabetics
NCT ID NCT06881888
Summary
This early-stage study is testing whether a medicine called octreotide, delivered as a nasal spray, can safely reduce swelling in the back of the eye (macular edema) caused by diabetes. It is for people whose eye swelling hasn't improved enough with the standard treatment of injections into the eye. Researchers will measure changes in eye thickness and vision to see if the nasal spray helps.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Alabama at Birmingham
Birmingham, Alabama, 35243, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.